The role of interleukin-2 in the treatment of cancer patients
ISBN/ASIN: 9789401047692,9789401117531 | 1993 | English | pdf | 191/191 pages | 4.32 Mb
Publisher: Springer Netherlands | Author: John Wagstaff (auth.), John Wagstaff MD, MB, ChB, MRCP (eds.) | Edition: 1
Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.